Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL5247 Target Snapshot

Integrin-linked protein kinase · SINGLE PROTEIN · Homo sapiens

453Compounds
71Assays
2Approved Drugs
556.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt Q13418. Use UniProt Q13418 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q13418 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Integrin-linked protein kinase as ChEMBL target CHEMBL5247, mapped to UniProt Q13418. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Integrin-linked protein kinase
SINGLE PROTEIN · Homo sapiens
As of 2026-09-13
ChEMBL target ID
CHEMBL5247
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
Q13418
Scaffold protein ILK
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Integrin-linked protein kinase is the right protein anchor across sources, using UniProt Q13418 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelScaffold protein ILK
UniProt AccessionQ13418
Component TypeProtein
Sequence Length452 aa

Scaffold protein ILK

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Integrin-linked protein kinase, mapped to UniProt Q13418. ChEMBL maps the protein component as Scaffold protein ILK. Sequence length is 452 aa.

Mapped IDQ13418
Review nameIntegrin-linked protein kinase
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

2
Approved
1
Phase III
1
Phase II
Assay Mix

Activity Type Distribution

IC50324.0
KD232.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL3681007 8.15 IC50 7.0 Preclinical
CHEMBL3681013 8.0 IC50 10.0 Preclinical
CHEMBL3685712 8.0 IC50 10.0 Preclinical
CHEMBL3639798 7.7 IC50 20.0 Preclinical
CHEMBL3685682 7.7 IC50 20.0 Preclinical
CHEMBL3685727 7.7 IC50 20.0 Preclinical
CHEMBL255863 7.7 Kd 20.0 Approved
CHEMBL3732995 7.52 IC50 30.0 Preclinical
CHEMBL2079588 7.5 Kd 32.0 Clinical
CHEMBL3680995 7.4 IC50 40.0 Preclinical
Distribution

pChEMBL Value Distribution

41
5.0
63
5.5
96
6.0
58
6.5
46
7.0
9
7.5
6
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

NILOTINIB
CHEMBL255863
Approved 2007
ERLOTINIB
CHEMBL553
Approved 2004
Assay Landscape

Assay Landscape

71
Total Assays
325
Tested Compounds
1
Assay Types
Binding — 71 assays, 325 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 34 155 6.3
subcellular format 20 3 7.0
single protein format 16 16 5.3
assay format 1 151 6.3

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine